Pharmacogenomics
About This Project
The study of the relationship between genes and response to drugs has been the subject of intensive research over the past two decades and robust evidence now exists to support testing under clinical conditions.
There is a great deal of variability in how a patient responds to medications due to the genes that govern drug metabolism, and this can therefore impact drug efficacy. Pharmacogenomics empowers the doctor to provide specific medical interventions, based on the patient’s genetic profile, and replaces the current trial and error approach to drug therapy.
A pharmacogenomics test gives insight into how each patient metabolizes, transports, and binds specific prescription drugs, which in turn allows physicians to prescribe those compounds that are most likely to prove efficacious, to avoid those that will not, and in many instances to adjust doses to safe yet therapeutic levels. Such a personalized approach to medicine has the power to produce better results, particularly for individuals whose genetic profile puts them at risk of experiencing either treatment failure or an adverse reaction from a given drug.
The mygeneRx test analyses 62 genetic variations within 20 genes and is able to give accurate and actionable recommendations on approximately 150 different prescription drugs.
mygeneRx
The mygeneRx test analyses 62 genetic variations within 20 genes and is able to give accurate and actionable recommendations on approximately 150 different prescription drugs. The report visually highlights significant results for rapid decision making.
Patients most likely to benefit from mygeneRx testing include those:
- Planning to start on a new medication
- Experiencing side effects to specific medications
- Not responding to specific medications
- Requiring doses outside the recommended range
mygeneRx can be tested in full, or as separate sub-products divided by medical speciality:
mycardioRx
There is a great deal of variability in how a patient responds to medications due to the genes that govern drug metabolism, and this can therefore impact drug efficacy. Pharmacogenomics empowers the doctor to provide specific medical interventions, based on the patient’s genetic profile, and replaces the current trial and error approach to drug therapy
mycardioRx analyses genetic variants that affect the metabolism of cardiovascular medications such as:
- Angiotensin II Receptor Antagonists
- Antianginal Agents
- Antiarrhythmics
- Anticoagulants
- Antiplatelets
- Beta Blockers
- Diuretics
- Statins
The benefits of pharmacogenomic testing include
- Improve efficacy of treatment, improved quality of life for the patient
- Decrease treatment time
- Save money on ineffective medications
mypsychRx
There is a great deal of variability in how a patient responds to medications due to the genes that govern drug metabolism, and this can therefore impact drug efficacy. Pharmacogenomics empowers the doctor to provide specific medical interventions, based on the patient’s genetic profile, and replaces the current trial and error approach to drug therapy.
mypsychRx analyses genetic variants that affect the metabolism of psychotropic medications such as:
- Antiaddictives
- Anti-ADHD Agents
- Anticonvulsants
- Antidementia Agents
- Antidepressants
- Antipsychotics
- Benzodiazepines
- Mood Stabilizers
Benefits of pharmacogenomic testing include
- Improve efficacy of treatment, improved quality of life for the patient
- Decrease treatment time
- Save money on ineffective medications
- Patients avoid unpleasant or possible fatal side effects of some medications
mypainRx
There is a great deal of variability in how a patient responds to medications due to the genes that govern drug metabolism, and this can therefore impact drug efficacy. Pharmacogenomics empowers the doctor to provide specific medical interventions, based on the patient’s genetic profile, and replaces the current trial and error approach to drug therapy.
mypainRx analyses genetic variants that affect the metabolism of pain medications such as:
- Fibromyalgia Agents
- Muscle Relaxants
- NSAIDs
- Opioids
Benefits of pharmacogenomic testing include
- Improve efficacy of treatment, improved quality of life for the patient
- Decrease treatment time
- Save money on ineffective medications
- Patients avoid unpleasant or possible fatal side effects of some medications